Acquistion of Thor Medical AS (NO) by Nordic Nanovector ASA (NO)

Carnegie acted as financial advisor to Nordic Nanovector in the acquisition of Thor Medical. Thor Medical, based in Oslo, Norway, has developed a proprietary technology for the manufacturing of radionuclides, primarily alpha-particle emitters from natural resources. The acquisition provides Nordic Nanovector with access to promising new technology that enables the development and production of radionuclides for radioimmunoconjugate-based approaches to cancer treatment, which is a rapidly growing market.